Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,260 | 346 | 87.8% |
| Consulting Fee | $1,013 | 1 | 12.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,485 | 24 | $0 (2024) |
| Galderma Laboratories, L.P. | $681.33 | 33 | $0 (2024) |
| Smith+Nephew, Inc. | $675.36 | 35 | $0 (2024) |
| Janssen Biotech, Inc. | $634.12 | 27 | $0 (2024) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $541.91 | 28 | $0 (2024) |
| PFIZER INC. | $502.90 | 25 | $0 (2024) |
| MAYNE PHARMA INC. | $300.18 | 13 | $0 (2022) |
| Sandoz Inc. | $265.89 | 14 | $0 (2020) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $261.61 | 13 | $0 (2024) |
| Lilly USA, LLC | $207.90 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,540 | 24 | ABBVIE INC. ($1,022) |
| 2023 | $907.53 | 36 | Janssen Biotech, Inc. ($249.84) |
| 2022 | $1,122 | 51 | Janssen Biotech, Inc. ($162.16) |
| 2021 | $892.83 | 39 | Ortho Dermatologics, a division of Bausch Health US, LLC ($182.01) |
| 2020 | $483.82 | 28 | Galderma Laboratories, L.P. ($82.13) |
| 2019 | $1,163 | 61 | Galderma Laboratories, L.P. ($233.26) |
| 2018 | $1,100 | 57 | Galderma Laboratories, L.P. ($226.80) |
| 2017 | $1,062 | 51 | Smith & Nephew, Inc. ($162.25) |
All Payment Transactions
347 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $35.98 | General |
| Category: Dermatology | ||||||
| 12/13/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $1,012.50 | General |
| 10/10/2024 | Solventum Corporation | ACTIV.A.C. (Device) | Food and Beverage | Cash or cash equivalent | $16.94 | General |
| Category: Negative Pressure Systems & Dressings | ||||||
| 09/26/2024 | Lilly USA, LLC | TALTZ (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $23.95 | General |
| Category: Immunology | ||||||
| 08/08/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: ANTIBIOTIC | ||||||
| 07/22/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $25.77 | General |
| Category: Immunology | ||||||
| 07/15/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $27.01 | General |
| Category: Immunology | ||||||
| 07/11/2024 | Kerecis Limited | Kerecis Omega3 SurgiClose (Device), Kerecis Omega3 Marigen, Kerecis Omega3 Marigen | Food and Beverage | Cash or cash equivalent | $18.79 | General |
| Category: Wound Care | ||||||
| 07/09/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $9.33 | General |
| 06/11/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $29.27 | General |
| Category: Immunology | ||||||
| 05/28/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $26.08 | General |
| Category: Inflammation/Rare Disease | ||||||
| 05/20/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | JUBLIA (Drug), Cabtreo, ARAZLO | Food and Beverage | In-kind items and services | $20.51 | General |
| Category: Podiatry | ||||||
| 05/16/2024 | Smith+Nephew, Inc. | PICO 7 (Device) | Food and Beverage | In-kind items and services | $21.81 | General |
| Category: Negative Pressure Wound Therapy | ||||||
| 04/26/2024 | PFIZER INC. | LITFULO (Drug) | Food and Beverage | In-kind items and services | $31.93 | General |
| Category: IMMUNOLOGY | ||||||
| 04/25/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $26.06 | General |
| Category: Immunology | ||||||
| 04/22/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $13.45 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 04/05/2024 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $24.34 | General |
| Category: Immunology | ||||||
| 03/08/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $29.02 | General |
| Category: Immunology | ||||||
| 03/05/2024 | Smith+Nephew, Inc. | COLLAGENASE SANTYL (Drug) | Food and Beverage | In-kind items and services | $23.82 | General |
| Category: Pharma Products | ||||||
| 03/04/2024 | Kerecis Limited | Kerecis Omega3 SurgiClose (Device), Kerecis Omega3 Marigen, Kerecis Omega3 GraftGuide | Food and Beverage | Cash or cash equivalent | $28.71 | General |
| Category: Wound Care | ||||||
| 02/26/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $33.01 | General |
| Category: Immunology | ||||||
| 02/23/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $13.10 | General |
| Category: Dermatology | ||||||
| 02/14/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $15.52 | General |
| 01/11/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug), Absorica LD | Food and Beverage | In-kind items and services | $18.68 | General |
| Category: Dermatology | ||||||
| 11/29/2023 | Ortho Dermatologics, a division of Bausch Health US, LLC | JUBLIA (Drug) | Food and Beverage | In-kind items and services | $12.92 | General |
| Category: Podiatry | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 274 | 320 | $56,696 | $27,007 |
| 2022 | 7 | 260 | 308 | $54,409 | $25,185 |
| 2021 | 6 | 223 | 258 | $44,672 | $21,350 |
| 2020 | 6 | 217 | 266 | $46,526 | $19,260 |
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 77 | 86 | $16,770 | $8,979 | 53.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 70 | 96 | $12,000 | $6,992 | 58.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 44 | 54 | $10,962 | $5,000 | 45.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 50 | 50 | $11,250 | $4,150 | 36.9% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 18 | 18 | $3,330 | $1,045 | 31.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 15 | 16 | $2,384 | $841.02 | 35.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 80 | 85 | $16,575 | $8,361 | 50.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 58 | 92 | $11,500 | $6,962 | 60.5% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 39 | 47 | $9,541 | $3,788 | 39.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 41 | 41 | $9,225 | $3,617 | 39.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 15 | 15 | $3,000 | $1,181 | 39.4% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 11 | 11 | $2,035 | $644.97 | 31.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 16 | 17 | $2,533 | $632.67 | 25.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 65 | 68 | $13,260 | $6,759 | 51.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 61 | 83 | $10,375 | $5,845 | 56.3% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 39 | 47 | $9,541 | $4,858 | 50.9% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 27 | 27 | $6,075 | $2,028 | 33.4% |
| 17000 | Destruction of skin growth | Office | 2021 | 17 | 19 | $2,831 | $1,060 | 37.4% |
| 99202 | New patient outpatient visit, total time 15-29 minutes | Office | 2021 | 14 | 14 | $2,590 | $800.14 | 30.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 72 | 92 | $17,940 | $7,438 | 41.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 55 | 77 | $9,625 | $4,525 | 47.0% |
| 17110 | Destruction of up to 14 skin growths | Office | 2020 | 33 | 40 | $8,120 | $3,841 | 47.3% |
| 99202 | New patient office or other outpatient visit, typically 20 minutes | Office | 2020 | 23 | 23 | $4,255 | $1,501 | 35.3% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 20 | 20 | $4,500 | $1,273 | 28.3% |
| 17000 | Destruction of skin growth | Office | 2020 | 14 | 14 | $2,086 | $682.05 | 32.7% |
About Dr. Dwana Shabazz, M.D
Dr. Dwana Shabazz, M.D is a Specialist healthcare provider based in Fairfax, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1548296817.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Dwana Shabazz, M.D has received a total of $8,272 in payments from pharmaceutical and medical device companies, with $1,540 received in 2024. These payments were reported across 347 transactions from 63 companies. The most common payment nature is "Food and Beverage" ($7,260).
As a Medicare-enrolled provider, Shabazz has provided services to 974 Medicare beneficiaries, totaling 1,152 services with total Medicare billing of $92,802. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Practice Information
- Specialty Specialist
- Other Specialties Dermatology
- Location Fairfax, VA
- Active Since 06/25/2006
- Last Updated 09/12/2017
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1548296817
Products in Payments
- EUCRISA (Drug) $447.53
- TREMFYA (Drug) $415.64
- JUBLIA (Drug) $384.15
- Humira (Biological) $322.18
- Santyl (Drug) $266.32
- KERYDIN (Drug) $265.89
- REMICADE (Biological) $218.48
- TALTZ (Drug) $207.90
- DORYX (Drug) $187.79
- EPIDUO FORTE (Drug) $186.08
- NUZYRA (Drug) $182.97
- SOOLANTRA (Drug) $172.90
- Winlevi (Drug) $172.90
- COLLAGENASE SANTYL (Drug) $149.47
- ORACEA (Drug) $143.28
- DERMATITIS - DISEASE (Drug) $125.07
- vitagel (Device) $119.48
- SKYRIZI (Biological) $119.41
- Puraply (Medical Supply) $114.24
- OPZELURA (Drug) $102.27
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Fairfax
Sandeep Khandhar, Md, MD
Specialist — Payments: $397,532
Hema Sundaram, M.d, M.D
Specialist — Payments: $264,716
Dr. Robin West, Md, MD
Specialist — Payments: $69,852
Yongsook Suh, M.d, M.D
Specialist — Payments: $15,454
Dr. Randall Wong, M.d, M.D
Specialist — Payments: $9,832
Dr. Homayoun Hashemi, M.d, M.D
Specialist — Payments: $8,782